Status:
COMPLETED
Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Infection
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The primary objective of this study is to assess the effect of a high-fat meal (breakfast) on the concentrations of moxidectin measured in the blood after a single oral administration in healthy subje...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Men or women of non childbearing potential aged 18 to 50 years inclusive at screening.
- Body mass index (BMI) in the range of 18.0 to 30.0 kg/m2 and body weight greater than or equal to 50 kg.
- Exclusion criteria
- Any clinical important deviation from normal limits in physical examination findings, vital sign measurements, electrocardiograms or clinical laboratory test results.
- Presence or history of any disorder that may prevent the successful completion of the study.
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00736697
Start Date
November 1 2008
End Date
May 1 2009
Last Update
February 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poitiers, France, 86000